SYNZYME TECHNOLOGY, INC.

Address

1 TECHNOLOGY DR, B-115
IRVINE, CA, 92618-

Information

DUNS: 36552925
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Polynitroxylated Pegylated Hemoglobin for Traumatic Brian Injury Resuscitation

    Amount: $1.00

    DESCRIPTION provided by applicant Traumatic brain injury TBI is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension Vulnerability of T ...

    SBIRPhase II2016Department of Health and Human Services
  2. Polynitroxylated Pegylated Hemoglobin for Traumatic Brian Injury Resuscitation

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension. Vulnerability of T ...

    SBIRPhase I2011Department of Health and Human Services
  3. STROMA-FREE HEMOGLOBIN and HBOC PRODUCTION

    Amount: $100,037.00

    Not Available

    SBIRPhase I2008Department of Health and Human Services
  4. PNA for Stroke

    Amount: $2,928,860.00

    DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death in the U.S. and is also a leading cause of severe, long-term disability. The total cost of stroke to the United States is ...

    SBIRPhase II2005Department of Health and Human Services
  5. TOPS-Ester: Pharmacokinetics and Imaging in Human Skin

    Amount: $100,003.00

    DESCRIPTION (provided by applicant): TOPS-ester is a topical drug selected for development for it's unique ability to compartmentalize within skin cells and express antioxidant activity that limits ox ...

    SBIRPhase I2003Department of Health and Human Services
  6. Brain Injury During CPR Prevented by Vascular Nitroxide

    Amount: $100,004.00

    DESCRIPTION (provided by applicant): The brain damage that frequently accompanies cardiac arrest and resuscitation is devastating. Fewer than 10% of cardiopulmonary resuscitation (CPR) attempts resul ...

    SBIRPhase I2003Department of Health and Human Services
  7. TOPS-ESTER MODULATION OF UVB-INDUCED IMMUNE SUPPRESSION

    Amount: $98,736.00

    DESCRIPTION (provided by applicant): A TOPS-ester, diethyl 2,2,6,6-tetramethyl-1-oxyl-4-piperidene succinate (DETOPS), is a topical drug selected for development for its unique ability to compartment ...

    SBIRPhase I2002Department of Health and Human Services
  8. POLYNITROXYL HEMOGLOBIN:NEUROPROTECTIVE OXYGEN CARRIER

    Amount: $100,044.00

    DESCRIPTION: (Investigator's abstract) Polynitroxyl hemoglobin (PNH) will be developed as a neuroprotective oxygen carrier. PNH is different from 1st generation hemoglobin-based ox ...

    SBIRPhase I2001Department of Health and Human Services
  9. NITROXIDE THERAPY FOR INFLAMMATORY BOWEL DISEASE

    Amount: $100,000.00

    DESCRIPTION (Adapted from the application): Free radicals play important roles in inflammatory bowel disease (IBD), and the reduction or elimination of the adverse effects of these oxida ...

    SBIRPhase I2001Department of Health and Human Services
  10. N/A

    Amount: $100,000.00

    Not Available Aspen Systems proposes to develop new Ultra-High Temperature Resistant Aerogels that will withstand temperatures as high as 2300 K for long periods of time. The new insulation will be ba ...

    SBIRPhase I2000Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government